Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats

scientific article published on July 1965

Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0041-008X(65)90050-5
P8608Fatcat IDrelease_6waw7opy5fajloqi2e3yypizse
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0041008X65900505?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0041008X65900505?httpAccept=text/xml
P698PubMed publication ID5839398

P2093author name stringBanks WF Jr
D. J. Sullivan
W. F. Banks
E. W. McChesney
P2860cites workPitfalls in a Discovery: The Chronicle of Chloroquine *Q34254657
STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618)Q35307420
OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.Q39838619
OBSERVATIONS ON EXPERIMENTAL CHLOROQUINE RETINOPATHY.Q41943790
THE PATHOLOGY OF CHLOROQUINE RETINOPATHY.Q41943979
HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY.Q41944165
PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.Q41944408
Ocular abnormalities in patients treated with synthetic antimalarial drugsQ76428819
Retinopathy following chloroquine therapyQ78766793
On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatismQ78836545
Studies on the chemotherapy of the human malarias; of the human malarias the physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinolineQ95783821
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
albinismQ81867
hydroxychloroquineQ421094
chloroquineQ422438
pigmentationQ14863538
P304page(s)627-636
P577publication date1965-07-01
P1433published inToxicology and Applied PharmacologyQ2446974
P1476titleMetabolism of chloroquine and hydroxychloroquine in albino and pigmented rats
P478volume7

Reverse relations

cites work (P2860)
Q42645380A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery
Q41920381A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes
Q41927799Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry
Q39772563Antimalarials in the management of discoid and systemic lupus erythematosus
Q33853468Antimalarials: unapproved uses or indications
Q41933743Blood platelets and chloroquine
Q88956497Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
Q41946459Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus
Q41923517Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis
Q41917055Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells
Q37238136Drug disposition in the mammalian eye and brain: a comparison of mechanisms
Q39608521Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
Q41941073Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy
Q33971717Ocular effects of chlorpromazine and oxypertine on beagle dogs
Q55060972Ocular effects of the venom from the spitting cobra (Naja nigricollis).
Q56806709Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts
Q99552022Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy
Q38561490Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
Q41922480Tissue and blood concentrations of chloroquine following chronic administration in the rat
Q41941274Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat
Q72258102Tumor localizing agents III Radioiodinated quinoline derivatives